Pemphigus vulgaris is an autoimmune skin disease that causes blisters and erosions of the mucous membranes, skin, or both. Rituximab is recommended as first-line therapy, but its effectiveness in comparison with a first-line glucocorticoid-sparing agent has not been extensively investigated. New research findings are summarized in a short video. https://nej.md/3vpTpBH | The New England Journal of Medicine

Pemphigus is an autoimmune blistering disease of the skin which if untreated, is potentially fatal. ⏳ Early diagnosis and correct treatment are essential. How should this disease be managed? 🔬It's very important to make an early and accurate diagnosis using specialized biopsy techniques, laboratories and serology to institute the correct treatment as soon as possible. 🎥Watch the video by Dédée Murrell and attend the session 📌 "Autoimmune bullous diseases" at #EADVCongress. 🗓 Thursday, 18 Sep